HAL
40
11
AMT
30
2
SYK
50
4
MU
42
14
ETN
64
4
CTAS
36
8
NI
63
5
CRM
65
6
M
40
3
NTAP
58
3
HES
49
2
MRK
25
2
RCL
74
5
DFS
64
4
IP
53
3
VRSN
59
4
OXY
42
17
CCI
30
2
DRI
74
5
FE
34
4
HAL
40
11
AMT
30
2
SYK
50
4
MU
42
14
ETN
64
4
CTAS
36
8
NI
63
5
CRM
65
6
M
40
3
NTAP
58
3
HES
49
2
MRK
25
2
RCL
74
5
DFS
64
4
IP
53
3
VRSN
59
4
OXY
42
17
CCI
30
2
DRI
74
5
FE
34
4
Financhill
Back

Pharmaron Beijing 10K Form

Sell
16

PHBBF
Pharmaron Beijing

Last Price:
$1.93
Seasonality Move:
0%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PHBBF News And Ratings

See the #1 stock for the next 7 days that we like better than PHBBF

PHBBF Financial Statistics

Sales & Book Value

Annual Sales: $1.5B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 1.56

Profitability

Net Income (TTM): $0
Gross Margin: $561M
Return on Equity: 0%
Return on Assets: 0%

Pharmaron Beijing Earnings Forecast

Key Pharmaron Beijing Financial Ratios

  • The Gross Profit Margin over the past 9 years for PHBBF is 36.71%.
  • The Selling, General & Administrative Expenses for PHBBF have been equal to 9.44% of Gross Profit Margin.
  • The Research & Development expenses have been 2.75% of Revenue.
  • The Interest Expense is 12.17% of Operating Income.
  • The Net Earning history of PHBBF is 13.39% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

Pharmaron Beijing Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: PHBBF
Website: pharmaron.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 11.17
Forward P/E Ratio: 0

PHBBF Technical Analysis vs Fundamental Analysis

Sell
16
Pharmaron Beijing (PHBBF) is a Sell

Is Pharmaron Beijing a Buy or a Sell?